Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene.
Chlorinated hydrocarbons are lipophilic, toxic, and persistent in the environment and animal tissues. They enter the body in food and are stored in adipose tissue. Loss of body fat through caloric restriction mobilizes stored lipophilic xenobiotics and results in distribution to other tissues. We have studied the reversibility of this process in mice that followed a regimen of body weight cycling. Weight gain was followed by weight loss, a second gain, and a second loss ("yo-yo diet regimen"). We measured the distribution of orally gavaged [14C]hexachlorobenzene, which is sparingly metabolized. We found that weight cycling has different effects in different organs. Continued weight loss resulted in a threefold increase of 14C amount and concentration in the brain. After weight regain, 14C in the brain decreased but then increased again after a second weight loss. Weight loss resulted in an increase in the concentration of 14C in adipose tissue without changing the total amount in that tissue. Weight loss and regain resulted in an increase of 14C in the liver, which reflected an increase of fat in the liver. The regimen of weight gain and loss was repeated in mice gavaged with [14C]hexachlorobenzene, with one group receiving the nonabsorbable fat olestra in the diet. Combined dietary olestra and caloric restriction caused a 30-fold increase in the rate of excretion of 14C relative to an ad libitum diet or a reduced caloric diet alone. Distribution of 14C into the brain resulting from the restricted diet was reduced by 50% by dietary olestra.
Jandacek
Ronald J
RJ
Department of Pathology and Laboratory Medicine, University of Cincinnati School of Medicine, Cincinnati, OH 45237, USA. Ronald.Jandacek@uc.edu
Anderson
Nicole
N
Liu
Min
M
Zheng
Shuqin
S
Yang
Qing
Q
Tso
Patrick
P
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000502:physiology; D031204:Caloric Restriction; D004764:Enterohepatic Circulation / Q000187:drug effects / Q000502:physiology; D019358:Fat Substitutes / Q000494:pharmacology*; D005227:Fatty Acids / Q000494:pharmacology*; D006581:Hexachlorobenzene / Q000493:pharmacokinetics*; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D013395:Sucrose / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014018:Tissue Distribution / Q000187:drug effects / Q000502:physiology; D015430:Weight Gain / Q000502:physiology*; D015431:Weight Loss / Q000502:physiology*
D019358:Fat Substitutes; D005227:Fatty Acids; D006581:Hexachlorobenzene; D013395:Sucrose; C013692:sucrose polyester